Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation
The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. AF is the most common clinically significant arrhythmia and is as...
Saved in:
Published in | Journal of the American College of Cardiology Vol. 59; no. 2; pp. 143 - 149 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
10.01.2012
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0735-1097 1558-3597 1558-3597 |
DOI | 10.1016/j.jacc.2011.08.068 |
Cover
Abstract | The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.
AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.
Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.
Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.
Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation. |
---|---|
AbstractList | The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.
AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.
Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.
Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.
Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation. ObjectivesThe purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. BackgroundAF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited. MethodsUsing data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions. ResultsAmong 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years. ConclusionsPeriprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation. Objectives The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. Background AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited. Methods Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions. Results Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years. Conclusions Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation. The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.OBJECTIVESThe purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.BACKGROUNDAF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.METHODSUsing data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.RESULTSAmong 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.CONCLUSIONSPeriprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation. |
Author | Hlatky, Mark A. Shah, Rashmee U. Freeman, James V. Shilane, David Wang, Paul J. Go, Alan S. |
AuthorAffiliation | Stanford University School of Medicine, Stanford, California Division of Research, Kaiser Permanente of Northern California, Oakland, California University of California at San Francisco, San Francisco, California |
AuthorAffiliation_xml | – name: Stanford University School of Medicine, Stanford, California – name: Division of Research, Kaiser Permanente of Northern California, Oakland, California – name: University of California at San Francisco, San Francisco, California |
Author_xml | – sequence: 1 givenname: Rashmee U. surname: Shah fullname: Shah, Rashmee U. email: rashmee.shah@cshs.org organization: Stanford University School of Medicine, Stanford, California – sequence: 2 givenname: James V. surname: Freeman fullname: Freeman, James V. organization: Stanford University School of Medicine, Stanford, California – sequence: 3 givenname: David surname: Shilane fullname: Shilane, David organization: Stanford University School of Medicine, Stanford, California – sequence: 4 givenname: Paul J. surname: Wang fullname: Wang, Paul J. organization: Stanford University School of Medicine, Stanford, California – sequence: 5 givenname: Alan S. surname: Go fullname: Go, Alan S. organization: Division of Research, Kaiser Permanente of Northern California, Oakland, California – sequence: 6 givenname: Mark A. surname: Hlatky fullname: Hlatky, Mark A. organization: Stanford University School of Medicine, Stanford, California |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25538424$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22222078$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl2L1DAUhoOsuB_6B7yQgog3zpi0SZqILAyDq8KC4gd4d0jTUydjJxmTzsL6602dGVcHXHvT9vR5356T856SIx88EvKQ0SmjTD5fTpfG2mlJGZtSNaVS3SEnTAg1qYSuj8gJrSsxYVTXx-Q0pSWlGWH6Hjkux4vW6oSk9zFYbDfR9MU8rNa9s2ZwwadnxQdchLR2g-ndj33N-DbX12iGYi_EVMy6AWMxN8MCx4dZ0__iiy7klyG67H3hmuj6bf0-uduZPuGD3f2MfL549Wn-ZnL57vXb-exyYqXiw6SURqGgdYNUlq2Sla057bpGV1YZ20iuqVKi4aLFkmNpaquk6DotWyWQUVWdkfOt73rTrLC16Ic8JqyjW5l4DcE4-PuLdwv4Gq5AVJwypbPB051BDN83mAZYuWQxj-ExbBJoxqXUmo_k4wNyGTbR5-mAidy-lpnM1KM_G_rdyX4dGXiyA0yypu-i8dalG06ISvGSZ05tORtDShE7sHlP49nmOVwPjMKYEFjCmBAYEwJUQV5_lpYH0r37raKXWxHmdV05jJCsQ5_37yLaAdrgbpefH8ht73xOWv8NrzHdHBWkEih8HHM7xpYxyiUtv2SDF_82-N_ffwLStv4g |
CODEN | JACCDI |
CitedBy_id | crossref_primary_10_1093_eurheartj_ehw210 crossref_primary_10_1161_CIRCEP_113_000768 crossref_primary_10_1111_jce_13494 crossref_primary_10_1007_s12170_013_0352_7 crossref_primary_10_1177_1089253212469840 crossref_primary_10_1016_j_jacep_2018_10_015 crossref_primary_10_1093_ejcts_ezw313 crossref_primary_10_1093_europace_euab198 crossref_primary_10_1093_europace_euad374 crossref_primary_10_1007_s15006_014_3580_y crossref_primary_10_1016_j_hrthm_2014_03_013 crossref_primary_10_1161_CIRCULATIONAHA_113_002449 crossref_primary_10_1007_s00399_014_0343_5 crossref_primary_10_1016_j_amjcard_2016_01_040 crossref_primary_10_1111_jce_13123 crossref_primary_10_1111_jce_14454 crossref_primary_10_1097_HCO_0000000000000348 crossref_primary_10_1093_europace_euv266 crossref_primary_10_1161_JAHA_120_019599 crossref_primary_10_1093_europace_eus305 crossref_primary_10_1093_europace_eus304 crossref_primary_10_1177_2333392820961887 crossref_primary_10_14336_AD_2016_0211 crossref_primary_10_1161_CIRCEP_113_000760 crossref_primary_10_35336_VA_2021_E_3_16 crossref_primary_10_1016_j_hrthm_2023_02_016 crossref_primary_10_1016_j_ijcard_2015_05_145 crossref_primary_10_1093_europace_euab296 crossref_primary_10_1007_s40520_023_02514_8 crossref_primary_10_1016_j_crad_2013_08_018 crossref_primary_10_1016_j_amjcard_2017_11_034 crossref_primary_10_1161_CIRCEP_113_001281 crossref_primary_10_1002_clc_23335 crossref_primary_10_1007_s11239_015_1181_y crossref_primary_10_1016_S0140_6736_16_31277_6 crossref_primary_10_1016_j_recesp_2020_10_022 crossref_primary_10_1111_jce_13142 crossref_primary_10_1007_s11936_014_0344_z crossref_primary_10_1016_j_jacep_2015_12_005 crossref_primary_10_1093_europace_euad361 crossref_primary_10_1586_erc_12_62 crossref_primary_10_1016_j_ijcard_2014_11_105 crossref_primary_10_1111_jce_12731 crossref_primary_10_1093_europace_euw378 crossref_primary_10_3904_kjm_2021_96_4_264 crossref_primary_10_1016_j_ahj_2015_04_005 crossref_primary_10_1016_j_jacep_2015_04_016 crossref_primary_10_1253_circj_CJ_17_1213 crossref_primary_10_1093_europace_euaa415 crossref_primary_10_4070_kcj_2017_0327 crossref_primary_10_1093_ageing_afaa139 crossref_primary_10_1093_europace_euu002 crossref_primary_10_1007_s11886_016_0783_0 crossref_primary_10_1186_s13019_024_02710_1 crossref_primary_10_1111_jce_13051 crossref_primary_10_1093_europace_euy295 crossref_primary_10_1111_jce_12194 crossref_primary_10_1161_CIRCULATIONAHA_113_003862 crossref_primary_10_1007_s10840_012_9673_6 crossref_primary_10_1097_MLR_0000000000000274 crossref_primary_10_1111_jce_13042 crossref_primary_10_1161_CIRCULATIONAHA_116_022388 crossref_primary_10_4070_kcj_2022_0078 crossref_primary_10_1016_j_jacc_2023_03_418 crossref_primary_10_1161_CIRCULATIONAHA_116_022261 crossref_primary_10_36290_med_2016_035 crossref_primary_10_1161_CIRCEP_122_011365 crossref_primary_10_1161_CIRCEP_121_009790 crossref_primary_10_1136_heartjnl_2020_318282 crossref_primary_10_1016_j_hrcr_2016_09_008 crossref_primary_10_1002_clc_22812 crossref_primary_10_1161_CIRCEP_117_005579 crossref_primary_10_1111_jce_15495 crossref_primary_10_1111_pace_14309 crossref_primary_10_1007_s10439_016_1641_3 crossref_primary_10_1007_s10840_019_00697_7 crossref_primary_10_1016_j_jacep_2016_06_002 crossref_primary_10_3111_13696998_2014_911185 crossref_primary_10_1111_jce_12303 crossref_primary_10_1093_europace_euv229 crossref_primary_10_2217_fca_15_64 crossref_primary_10_1016_j_repce_2017_09_012 crossref_primary_10_1016_j_cger_2012_07_004 crossref_primary_10_1016_j_ahj_2015_05_018 crossref_primary_10_1016_j_amjcard_2017_07_057 crossref_primary_10_1016_j_jacc_2012_12_002 crossref_primary_10_1016_j_hrthm_2015_02_020 crossref_primary_10_1016_j_ijcard_2014_04_250 crossref_primary_10_1161_JAHA_115_001901 crossref_primary_10_1007_s12181_017_0146_0 crossref_primary_10_1111_pace_13905 crossref_primary_10_1007_s00380_021_01860_9 crossref_primary_10_1161_JAHA_118_009294 crossref_primary_10_1111_jce_14838 crossref_primary_10_1053_j_semtcvs_2012_04_007 crossref_primary_10_1016_j_jacep_2018_01_015 crossref_primary_10_1016_j_jacep_2016_02_005 crossref_primary_10_1002_prp2_880 crossref_primary_10_1007_s11886_013_0406_y crossref_primary_10_1161_JAHA_120_016071 crossref_primary_10_1016_j_hrthm_2017_05_012 crossref_primary_10_1093_eurheartj_ehz085 crossref_primary_10_1093_europace_eux274 crossref_primary_10_1016_j_ultrasmedbio_2016_03_007 crossref_primary_10_1007_s00399_017_0486_2 crossref_primary_10_1016_j_amjcard_2012_10_013 crossref_primary_10_1016_j_jacep_2016_12_015 crossref_primary_10_1093_europace_eux034 crossref_primary_10_1111_jvim_17251 crossref_primary_10_1093_europace_eus378 crossref_primary_10_1016_j_jacc_2014_03_022 crossref_primary_10_5402_2012_376071 crossref_primary_10_7759_cureus_45082 crossref_primary_10_1161_CIRCEP_118_006754 crossref_primary_10_1093_europace_euy131 crossref_primary_10_1111_jce_14737 crossref_primary_10_1093_europace_eus393 crossref_primary_10_1111_jgs_14483 crossref_primary_10_1161_CIR_0000000000000041 crossref_primary_10_1111_jce_13081 crossref_primary_10_1111_jce_13083 crossref_primary_10_1093_eurheartj_ehy452 crossref_primary_10_1111_j_1540_8167_2012_02381_x crossref_primary_10_1111_jce_13311 crossref_primary_10_1093_ejcts_ezt584 crossref_primary_10_1016_j_jacep_2017_05_005 crossref_primary_10_7759_cureus_40649 crossref_primary_10_1016_j_jacep_2022_02_014 crossref_primary_10_1097_JXX_0000000000000424 crossref_primary_10_1016_j_ahj_2015_10_015 crossref_primary_10_1016_j_jacep_2018_04_006 crossref_primary_10_1093_europace_eut004 crossref_primary_10_1161_CIRCEP_113_000597 crossref_primary_10_35336_VA_2020_3_9_24 crossref_primary_10_1093_eurheartj_ehw285 crossref_primary_10_1016_j_jacc_2013_09_026 crossref_primary_10_1136_heartjnl_2013_304592 crossref_primary_10_1093_eurheartj_ehaa612 crossref_primary_10_1161_CIRCULATIONAHA_112_109330 crossref_primary_10_1111_jce_12338 crossref_primary_10_1111_jce_14878 crossref_primary_10_1186_s12911_023_02347_5 crossref_primary_10_3390_jpm10030082 crossref_primary_10_1016_j_hrthm_2014_10_038 crossref_primary_10_1185_03007995_2014_922061 crossref_primary_10_1016_j_repc_2017_09_005 crossref_primary_10_1093_eurheartj_ehs253 crossref_primary_10_1016_j_hrthm_2014_08_021 crossref_primary_10_1089_jwh_2016_6282 crossref_primary_10_1007_s10840_022_01370_2 crossref_primary_10_1253_circrep_CR_21_0105 crossref_primary_10_1007_s10840_016_0141_6 crossref_primary_10_5124_jkma_2016_59_5_374 crossref_primary_10_1161_STROKEAHA_117_018501 crossref_primary_10_1007_s00399_017_0484_4 crossref_primary_10_1016_j_jtcvs_2012_07_065 crossref_primary_10_1016_j_ijcard_2012_12_088 crossref_primary_10_1161_JAHA_119_012595 crossref_primary_10_1016_j_joa_2012_03_003 crossref_primary_10_1177_201010581502400103 crossref_primary_10_1016_j_recesp_2012_11_001 crossref_primary_10_1586_14779072_2015_1011128 crossref_primary_10_1016_j_jacc_2013_09_004 crossref_primary_10_4236_wjcd_2016_65015 crossref_primary_10_1016_j_cjca_2014_08_001 crossref_primary_10_1016_j_amjcard_2019_10_048 crossref_primary_10_1111_jvim_16473 crossref_primary_10_1016_j_ipej_2017_10_001 crossref_primary_10_1007_s15006_012_0391_x crossref_primary_10_1093_europace_euy213 crossref_primary_10_36469_9881 crossref_primary_10_1038_nrcardio_2018_20 crossref_primary_10_1016_j_crvasa_2012_12_002 crossref_primary_10_1111_pace_13041 crossref_primary_10_1002_joa3_12378 crossref_primary_10_1016_j_jacep_2020_02_009 crossref_primary_10_1016_j_amjcard_2012_11_026 crossref_primary_10_1111_pace_14013 crossref_primary_10_1007_s15027_012_0027_1 crossref_primary_10_5937_siks1404261L crossref_primary_10_1111_jce_13471 crossref_primary_10_1111_jce_15893 crossref_primary_10_1016_j_hrthm_2017_04_042 crossref_primary_10_1007_s10840_018_0503_3 crossref_primary_10_1111_jce_13118 crossref_primary_10_2217_cer_2021_0170 crossref_primary_10_1016_j_jacep_2017_06_010 crossref_primary_10_1016_j_joa_2017_07_001 crossref_primary_10_1093_europace_euac068 crossref_primary_10_1161_CIRCEP_115_002890 crossref_primary_10_1016_j_hrthm_2014_07_017 crossref_primary_10_1111_pace_13971 crossref_primary_10_1186_s12872_020_01446_9 crossref_primary_10_1111_pace_12771 crossref_primary_10_1093_europace_euw295 crossref_primary_10_1007_s10840_019_00683_z crossref_primary_10_1016_j_asjsur_2024_07_105 crossref_primary_10_1161_CIRCULATIONAHA_113_006197 crossref_primary_10_1016_j_ijcard_2022_06_019 crossref_primary_10_1111_j_1540_8167_2012_02318_x crossref_primary_10_1016_j_amjcard_2017_03_006 crossref_primary_10_1007_s12170_019_0635_8 crossref_primary_10_1016_j_jacc_2011_08_070 |
Cites_doi | 10.1016/S0002-8703(03)00079-6 10.1001/jama.291.2.195 10.1016/j.hrthm.2009.06.009 10.1001/jama.2010.748 10.1001/jama.285.18.2370 10.1016/j.jacc.2010.07.007 10.1161/01.CIR.0000157153.30978.67 10.1161/CIRCULATIONAHA.108.814996 10.1093/europace/eum120 10.1093/eurheartj/ehi583 10.1161/CIRCINTERVENTIONS.109.860494 10.1016/S0002-9149(97)00309-3 10.1001/archneur.59.12.1877 10.1056/NEJMsa0907130 10.1001/jama.293.21.2634 10.1016/j.jacc.2010.05.061 10.1161/CIRCULATIONAHA.105.595140 10.1136/bmj.39513.555150.BE 10.1016/j.jacc.2009.04.076 10.1016/j.hrthm.2007.06.016 10.1016/j.amjcard.2006.01.048 |
ContentType | Journal Article |
Copyright | 2012 American College of Cardiology Foundation American College of Cardiology Foundation 2015 INIST-CNRS Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited Jan 10, 2012 |
Copyright_xml | – notice: 2012 American College of Cardiology Foundation – notice: American College of Cardiology Foundation – notice: 2015 INIST-CNRS – notice: Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Jan 10, 2012 |
DBID | 6I. AAFTH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK H94 K9. NAPCQ 7X8 5PM |
DOI | 10.1016/j.jacc.2011.08.068 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-3597 |
EndPage | 149 |
ExternalDocumentID | PMC5340189 3243191911 22222078 25538424 10_1016_j_jacc_2011_08_068 S073510971104602X 1_s2_0_S073510971104602X |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | California United States--US |
GeographicLocations_xml | – name: California – name: United States--US |
GrantInformation_xml | – fundername: American Heart Association – fundername: National Institutes of Health grantid: 5UL1RR025744 – fundername: Stanford NIH/NCRR CTSA grantid: KL2RR025743 – fundername: NCRR NIH HHS grantid: UL1 RR025744 – fundername: NCRR NIH HHS grantid: 5UL1RR025744 – fundername: NCRR NIH HHS grantid: KL2RR025743 – fundername: NCRR NIH HHS grantid: KL2 RR025743 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AABNK AABVL AAEDT AAEDW AAIKJ AAOAW AAQFI AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABOCM ABWVN ABXDB ACGFO ACGFS ACIUM ACJTP ACPRK ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRAH AFRHN AFTJW AGCQF AGHFR AGYEJ AHMBA AIGII AITUG AJRQY AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CS3 DIK DU5 E3Z EBS EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 H13 HVGLF HZ~ IHE IXB J1W K-O KQ8 L7B MO0 N9A O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 ROL RPZ SCC SDF SDG SDP SES SSZ TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R .55 .GJ 0SF 1CY 29L 3O- 3V. 6I. 7RV AACTN AAFTH AAKUH AALRI AAQQT AAQXK AAYOK ABMZM ABVKL AFCTW AFETI AFFNX AJOXV AMFUW ASPBG AVWKF AZFZN BENPR BPHCQ FGOYB HX~ J5H N4W NCXOZ QTD R2- RIG SEW T5K X7M XPP YYP ZGI ZXP AAIAV ABJNI EFLBG LCYCR NAHTW ZA5 AAYWO AAYXX AGQPQ CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK H94 K9. NAPCQ 7X8 ~HD 5PM |
ID | FETCH-LOGICAL-c684t-26a8e507be062d863c740ffb93c8acb6490885b45de24e2a7c865ff96d85e1083 |
IEDL.DBID | .~1 |
ISSN | 0735-1097 1558-3597 |
IngestDate | Thu Aug 21 13:59:47 EDT 2025 Sun Sep 28 08:25:14 EDT 2025 Sat Jul 26 03:03:47 EDT 2025 Mon Jul 21 06:04:49 EDT 2025 Mon Jul 21 09:14:35 EDT 2025 Thu Apr 24 23:01:42 EDT 2025 Tue Jul 01 03:41:20 EDT 2025 Fri Feb 23 02:28:22 EST 2024 Sun Feb 23 10:19:08 EST 2025 Tue Aug 26 16:32:50 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | atrial fibrillation complication ICD-9 outcomes AF pulmonary vein isolation International Classification of Diseases-9th Edition Arrhythmia Rehospitalization Heart disease Atrial fibrillation Catheter Cardiovascular disease Complication Procedure Circulatory system Cardiology Ablation Excitability disorder |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c684t-26a8e507be062d863c740ffb93c8acb6490885b45de24e2a7c865ff96d85e1083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Bruce D. Lindsay, MD, served as Guest Editor for this paper. The first two authors contributed equally to this work. |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S073510971104602X |
PMID | 22222078 |
PQID | 1506296466 |
PQPubID | 2031078 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5340189 proquest_miscellaneous_914669949 proquest_journals_1506296466 pubmed_primary_22222078 pascalfrancis_primary_25538424 crossref_citationtrail_10_1016_j_jacc_2011_08_068 crossref_primary_10_1016_j_jacc_2011_08_068 elsevier_sciencedirect_doi_10_1016_j_jacc_2011_08_068 elsevier_clinicalkeyesjournals_1_s2_0_S073510971104602X elsevier_clinicalkey_doi_10_1016_j_jacc_2011_08_068 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-01-10 |
PublicationDateYYYYMMDD | 2012-01-10 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
PublicationTitle | Journal of the American College of Cardiology |
PublicationTitleAlternate | J Am Coll Cardiol |
PublicationYear | 2012 |
Publisher | Elsevier Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
References | Curtis, Schreiner, Wang (bib8) 2009; 54 Ahmed, Piper, Malenka (bib14) 2009; 2 Argulian, Patel, Abramson (bib16) 2006; 98 Miyasaka, Barnes, Gersh (bib2) 2006; 114 Bueno, Ross, Wang (bib11) 2010; 303 Feasby, Quan, Ghali (bib19) 2002; 59 Wazni, Marrouche, Martin (bib12) 2005; 293 Juergens, Semsarian, Keech, Beller, Harris (bib18) 1997; 80 Bertaglia, Zoppo, Tondo (bib9) 2007; 4 Peterson, Coombs, DeLong, Haan, Ferguson (bib21) 2004; 291 Ellis, Culler, Simon, Reynolds (bib6) 2009; 6 Calkins, Brugada, Packer (bib10) 2007; 9 Weerasooriya, Khairy, Litalien (bib5) 2011; 57 Freeman, Wang, Curtis, Heidenreich, Hlatky (bib20) 2010; 56 (bib7) 2005–2009 Piper, Malenka, Ryan (bib15) 2003; 145 Cheng, Morrow, Sloan, Antman, Sabatine (bib17) 2009; 119 Ross, Normand, Wang (bib22) 2010; 362 Go, Hylek, Phillips (bib1) 2001; 285 Lubitz, Fischer, Fuster (bib3) 2008; 336 Cappato, Calkins, Chen (bib4) 2005; 111 Stabile, Bertaglia, Senatore (bib13) 2006; 27 (10.1016/j.jacc.2011.08.068_bib7) 2005 Go (10.1016/j.jacc.2011.08.068_bib1) 2001; 285 Feasby (10.1016/j.jacc.2011.08.068_bib19) 2002; 59 Ahmed (10.1016/j.jacc.2011.08.068_bib14) 2009; 2 Calkins (10.1016/j.jacc.2011.08.068_bib10) 2007; 9 Cheng (10.1016/j.jacc.2011.08.068_bib17) 2009; 119 Juergens (10.1016/j.jacc.2011.08.068_bib18) 1997; 80 Bertaglia (10.1016/j.jacc.2011.08.068_bib9) 2007; 4 Argulian (10.1016/j.jacc.2011.08.068_bib16) 2006; 98 Weerasooriya (10.1016/j.jacc.2011.08.068_bib5) 2011; 57 Ellis (10.1016/j.jacc.2011.08.068_bib6) 2009; 6 Curtis (10.1016/j.jacc.2011.08.068_bib8) 2009; 54 Stabile (10.1016/j.jacc.2011.08.068_bib13) 2006; 27 Piper (10.1016/j.jacc.2011.08.068_bib15) 2003; 145 Bueno (10.1016/j.jacc.2011.08.068_bib11) 2010; 303 Cappato (10.1016/j.jacc.2011.08.068_bib4) 2005; 111 Ross (10.1016/j.jacc.2011.08.068_bib22) 2010; 362 Miyasaka (10.1016/j.jacc.2011.08.068_bib2) 2006; 114 Wazni (10.1016/j.jacc.2011.08.068_bib12) 2005; 293 Freeman (10.1016/j.jacc.2011.08.068_bib20) 2010; 56 Peterson (10.1016/j.jacc.2011.08.068_bib21) 2004; 291 Lubitz (10.1016/j.jacc.2011.08.068_bib3) 2008; 336 15723973 - Circulation. 2005 Mar 8;111(9):1100-5 20335587 - N Engl J Med. 2010 Mar 25;362(12):1110-8 11343485 - JAMA. 2001 May 9;285(18):2370-5 21211687 - J Am Coll Cardiol. 2011 Jan 11;57(2):160-6 J Am Coll Cardiol. 2012 Apr 17;59(16):1492 20863954 - J Am Coll Cardiol. 2010 Sep 28;56(14):1133-9 15928285 - JAMA. 2005 Jun 1;293(21):2634-40 19716081 - Heart Rhythm. 2009 Sep;6(9):1267-73 12796758 - Am Heart J. 2003 Jun;145(6):1022-9 17599941 - Europace. 2007 Jun;9(6):335-79 17905330 - Heart Rhythm. 2007 Oct;4(10):1265-71 9230150 - Am J Cardiol. 1997 Jul 15;80(2):150-4 22222079 - J Am Coll Cardiol. 2012 Jan 10;59(2):150-2 18403546 - BMJ. 2008 Apr 12;336(7648):819-26 19237657 - Circulation. 2009 Mar 10;119(9):1195-202 16818816 - Circulation. 2006 Jul 11;114(2):119-25 20031752 - Circ Cardiovasc Interv. 2009 Oct;2(5):423-9 20516414 - JAMA. 2010 Jun 2;303(21):2141-7 14722145 - JAMA. 2004 Jan 14;291(2):195-201 16214831 - Eur Heart J. 2006 Jan;27(2):216-21 19712799 - J Am Coll Cardiol. 2009 Sep 1;54(10):903-7 12470174 - Arch Neurol. 2002 Dec;59(12):1877-81 16784919 - Am J Cardiol. 2006 Jul 1;98(1):48-53 |
References_xml | – volume: 303 start-page: 2141 year: 2010 end-page: 2147 ident: bib11 article-title: Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006 publication-title: JAMA – volume: 98 start-page: 48 year: 2006 end-page: 53 ident: bib16 article-title: Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions publication-title: Am J Cardiol – volume: 80 start-page: 150 year: 1997 end-page: 154 ident: bib18 article-title: Hemorrhagic complications of intravenous heparin use publication-title: Am J Cardiol – volume: 57 start-page: 160 year: 2011 end-page: 166 ident: bib5 article-title: Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? publication-title: J Am Coll Cardiol – volume: 56 start-page: 1133 year: 2010 end-page: 1139 ident: bib20 article-title: The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry publication-title: J Am Coll Cardiol – volume: 6 start-page: 1267 year: 2009 end-page: 1273 ident: bib6 article-title: Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries publication-title: Heart Rhythm – volume: 4 start-page: 1265 year: 2007 end-page: 1271 ident: bib9 article-title: Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety publication-title: Heart Rhythm – volume: 362 start-page: 1110 year: 2010 end-page: 1118 ident: bib22 article-title: Hospital volume and 30-day mortality for three common medical conditions publication-title: N Engl J Med – volume: 59 start-page: 1877 year: 2002 end-page: 1881 ident: bib19 article-title: Hospital and surgeon determinants of carotid endarterectomy outcomes publication-title: Arch Neurol – volume: 2 start-page: 423 year: 2009 end-page: 429 ident: bib14 article-title: Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry publication-title: Circ Cardiovasc Interv – year: 2005–2009 ident: bib7 article-title: HCUP State Inpatient Databases (SID) – volume: 291 start-page: 195 year: 2004 end-page: 201 ident: bib21 article-title: Procedural volume as a marker of quality for CABG surgery publication-title: JAMA – volume: 145 start-page: 1022 year: 2003 end-page: 1029 ident: bib15 article-title: Predicting vascular complications in percutaneous coronary interventions publication-title: Am Heart J – volume: 114 start-page: 119 year: 2006 end-page: 125 ident: bib2 article-title: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence publication-title: Circulation – volume: 119 start-page: 1195 year: 2009 end-page: 1202 ident: bib17 article-title: Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction publication-title: Circulation – volume: 111 start-page: 1100 year: 2005 end-page: 1105 ident: bib4 article-title: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation publication-title: Circulation – volume: 336 start-page: 819 year: 2008 end-page: 826 ident: bib3 article-title: Catheter ablation for atrial fibrillation publication-title: BMJ – volume: 9 start-page: 335 year: 2007 end-page: 379 ident: bib10 article-title: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up publication-title: Europace – volume: 293 start-page: 2634 year: 2005 end-page: 2640 ident: bib12 article-title: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial publication-title: JAMA – volume: 27 start-page: 216 year: 2006 end-page: 221 ident: bib13 article-title: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study) publication-title: Eur Heart J – volume: 54 start-page: 903 year: 2009 end-page: 907 ident: bib8 article-title: All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients publication-title: J Am Coll Cardiol – volume: 285 start-page: 2370 year: 2001 end-page: 2375 ident: bib1 article-title: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study publication-title: JAMA – volume: 145 start-page: 1022 year: 2003 ident: 10.1016/j.jacc.2011.08.068_bib15 article-title: Predicting vascular complications in percutaneous coronary interventions publication-title: Am Heart J doi: 10.1016/S0002-8703(03)00079-6 – volume: 291 start-page: 195 year: 2004 ident: 10.1016/j.jacc.2011.08.068_bib21 article-title: Procedural volume as a marker of quality for CABG surgery publication-title: JAMA doi: 10.1001/jama.291.2.195 – volume: 6 start-page: 1267 year: 2009 ident: 10.1016/j.jacc.2011.08.068_bib6 article-title: Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2009.06.009 – volume: 303 start-page: 2141 year: 2010 ident: 10.1016/j.jacc.2011.08.068_bib11 article-title: Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006 publication-title: JAMA doi: 10.1001/jama.2010.748 – volume: 285 start-page: 2370 year: 2001 ident: 10.1016/j.jacc.2011.08.068_bib1 article-title: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study publication-title: JAMA doi: 10.1001/jama.285.18.2370 – volume: 56 start-page: 1133 year: 2010 ident: 10.1016/j.jacc.2011.08.068_bib20 article-title: The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.07.007 – volume: 111 start-page: 1100 year: 2005 ident: 10.1016/j.jacc.2011.08.068_bib4 article-title: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation publication-title: Circulation doi: 10.1161/01.CIR.0000157153.30978.67 – volume: 119 start-page: 1195 year: 2009 ident: 10.1016/j.jacc.2011.08.068_bib17 article-title: Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.814996 – year: 2005 ident: 10.1016/j.jacc.2011.08.068_bib7 – volume: 9 start-page: 335 year: 2007 ident: 10.1016/j.jacc.2011.08.068_bib10 article-title: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up publication-title: Europace doi: 10.1093/europace/eum120 – volume: 27 start-page: 216 year: 2006 ident: 10.1016/j.jacc.2011.08.068_bib13 article-title: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi583 – volume: 2 start-page: 423 year: 2009 ident: 10.1016/j.jacc.2011.08.068_bib14 article-title: Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry publication-title: Circ Cardiovasc Interv doi: 10.1161/CIRCINTERVENTIONS.109.860494 – volume: 80 start-page: 150 year: 1997 ident: 10.1016/j.jacc.2011.08.068_bib18 article-title: Hemorrhagic complications of intravenous heparin use publication-title: Am J Cardiol doi: 10.1016/S0002-9149(97)00309-3 – volume: 59 start-page: 1877 year: 2002 ident: 10.1016/j.jacc.2011.08.068_bib19 article-title: Hospital and surgeon determinants of carotid endarterectomy outcomes publication-title: Arch Neurol doi: 10.1001/archneur.59.12.1877 – volume: 362 start-page: 1110 year: 2010 ident: 10.1016/j.jacc.2011.08.068_bib22 article-title: Hospital volume and 30-day mortality for three common medical conditions publication-title: N Engl J Med doi: 10.1056/NEJMsa0907130 – volume: 293 start-page: 2634 year: 2005 ident: 10.1016/j.jacc.2011.08.068_bib12 article-title: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial publication-title: JAMA doi: 10.1001/jama.293.21.2634 – volume: 57 start-page: 160 year: 2011 ident: 10.1016/j.jacc.2011.08.068_bib5 article-title: Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.05.061 – volume: 114 start-page: 119 year: 2006 ident: 10.1016/j.jacc.2011.08.068_bib2 article-title: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.595140 – volume: 336 start-page: 819 year: 2008 ident: 10.1016/j.jacc.2011.08.068_bib3 article-title: Catheter ablation for atrial fibrillation publication-title: BMJ doi: 10.1136/bmj.39513.555150.BE – volume: 54 start-page: 903 year: 2009 ident: 10.1016/j.jacc.2011.08.068_bib8 article-title: All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.04.076 – volume: 4 start-page: 1265 year: 2007 ident: 10.1016/j.jacc.2011.08.068_bib9 article-title: Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2007.06.016 – volume: 98 start-page: 48 year: 2006 ident: 10.1016/j.jacc.2011.08.068_bib16 article-title: Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.01.048 – reference: 20031752 - Circ Cardiovasc Interv. 2009 Oct;2(5):423-9 – reference: 11343485 - JAMA. 2001 May 9;285(18):2370-5 – reference: 21211687 - J Am Coll Cardiol. 2011 Jan 11;57(2):160-6 – reference: 15928285 - JAMA. 2005 Jun 1;293(21):2634-40 – reference: 19237657 - Circulation. 2009 Mar 10;119(9):1195-202 – reference: 18403546 - BMJ. 2008 Apr 12;336(7648):819-26 – reference: 16818816 - Circulation. 2006 Jul 11;114(2):119-25 – reference: 19716081 - Heart Rhythm. 2009 Sep;6(9):1267-73 – reference: 19712799 - J Am Coll Cardiol. 2009 Sep 1;54(10):903-7 – reference: 22222079 - J Am Coll Cardiol. 2012 Jan 10;59(2):150-2 – reference: 20335587 - N Engl J Med. 2010 Mar 25;362(12):1110-8 – reference: 16784919 - Am J Cardiol. 2006 Jul 1;98(1):48-53 – reference: 12470174 - Arch Neurol. 2002 Dec;59(12):1877-81 – reference: 16214831 - Eur Heart J. 2006 Jan;27(2):216-21 – reference: 17905330 - Heart Rhythm. 2007 Oct;4(10):1265-71 – reference: 9230150 - Am J Cardiol. 1997 Jul 15;80(2):150-4 – reference: 15723973 - Circulation. 2005 Mar 8;111(9):1100-5 – reference: 17599941 - Europace. 2007 Jun;9(6):335-79 – reference: 20863954 - J Am Coll Cardiol. 2010 Sep 28;56(14):1133-9 – reference: - J Am Coll Cardiol. 2012 Apr 17;59(16):1492 – reference: 12796758 - Am Heart J. 2003 Jun;145(6):1022-9 – reference: 14722145 - JAMA. 2004 Jan 14;291(2):195-201 – reference: 20516414 - JAMA. 2010 Jun 2;303(21):2141-7 |
SSID | ssj0006819 |
Score | 2.5034678 |
Snippet | The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization... ObjectivesThe purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat... Objectives The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 143 |
SubjectTerms | Adult Aged Aged, 80 and over atrial fibrillation Atrial Fibrillation - surgery Biological and medical sciences California Cardiac arrhythmia Cardiac dysrhythmias Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Catheter Ablation - adverse effects Catheters complication Female Heart Hospitalization Hospitals Humans Male Medical sciences Middle Aged outcomes Patient Readmission - statistics & numerical data pulmonary vein isolation Reoperation - statistics & numerical data Treatment Outcome |
Title | Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S073510971104602X https://www.clinicalkey.es/playcontent/1-s2.0-S073510971104602X https://dx.doi.org/10.1016/j.jacc.2011.08.068 https://www.ncbi.nlm.nih.gov/pubmed/22222078 https://www.proquest.com/docview/1506296466 https://www.proquest.com/docview/914669949 https://pubmed.ncbi.nlm.nih.gov/PMC5340189 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemPSAkhPgmMCY_8MZCE8d27cdSUQ2k8QBM6pvlr2idpqwi3St_O3eJk7YwhkQfqtbxpbXvfL7Iv7sfIW-9LXmskdCkYCHnpZW51XWZR6ZtqINykmO-89kXeXrOPy_F8oDMh1wYhFUm39_79M5bp5ZJms3JerWafAPjFHh-WuIxZcGWmMHOp2jr739uYR5SdeQe2DnH3ilxpsd4XVrvd8p4qr9tTg_WtoUpq3uui9uC0d8xlTub1OIReZiiSzrrB_CYHMTmCbl3ls7Pn5K2ywsIWGqDznfB5Cf0a7xIFCJDZuYJtU2A9jW4azoIxpbOkFacdqmD-GHmejgdhfCXzjoWELrARIKrvv0ZOV98_D4_zRPtQu6l4pucSasihIkuFpIFJSs_5UVdO115ZT0oD6FRwnERIuOR2alXUtS1lkGJWEJI95wcNtdNfEmodcyBCwmldg5Uo6ysXNAerEaWATSSkXKYb-NTTXKkxrgyA_js0qCODOrIIF-mVBl5N8qs-4ocd_auBjWaIdcUvKOBDeNOqeltUrFNC7w1pWmZKcwfRpgRMUru2fE_f_F4z8bGocEjX6U44xk5GozObP-FABVpyaXMCB0vg4PAUx_bxOub1mjYC6XWXGfkRW-i23vjC2JEGO6e8Y4dsPb4_pVmddHVIBcVPJgr_eo_h_ua3IdvCAqCRXlEDjc_buIbiO427rhbvvD-afnhFxGrUGw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGkAAJIb4JjOEH3li0xHFc-7FUVB2se4BN6pvlr2idpqwi3f_PXeJkLYwh0afK9jW17-fzRb67HyEfncl5qJDQJGM-5bkRqVFVngamjK-8tIJjvvP8RMzO-NdFudghkz4XBsMqo-3vbHprrWPLYVzNw9VyefgDwFni_WmO15QZW9wj98EbyBDaR4vPgzkWsmX3wNEpDo-ZM12Q14VxbqOOp_zb6fR4ZRpYs6oju7jNG_09qHLjlJo-JU-ie0nH3QyekZ1QPycP5vEC_QVp2sQAj7U26GQzmvyAfg_nkUOkT808oKb20L4Ce017wdDQMfKK0zZ3EL-MbRdPR8H_peOWBoROMZPgsmt_Sc6mX04nszTyLqROSL5OmTAygJ9oQyaYl6JwI55VlVWFk8aB9jA2qrS89IHxwMzISVFWlRJeliEHn-4V2a2v6vCGUGOZBRvic2UtHxXSiMJ65QA2IvegkYTk_XprF4uSIzfGpe6jzy406kijjjQSZgqZkE-DzKoryXHn6KJXo-6TTcE8ajgx7pQa3SYVmrjDG53rhulM_4HChJSD5BaQ__nE_S2MDVODd75CcsYTsteDTt_8ixJUpAQXIiF06AYLgdc-pg5X141WcBgKpbhKyOsOoje_jR9wEmG6W-AdBmDx8e2eenneFiEvC3gzl-rtf073A3k4O50f6-Ojk2_vyCPowQgh2KB7ZHf98zq8B1dvbffbrfwLGplSlQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Procedural+Complications%2C+Rehospitalizations%2C+and+Repeat+Procedures+After+Catheter+Ablation+for+Atrial+Fibrillation&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Shah%2C+Rashmee+U.&rft.au=Freeman%2C+James+V.&rft.au=Shilane%2C+David&rft.au=Wang%2C+Paul+J.&rft.date=2012-01-10&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.volume=59&rft.issue=2&rft.spage=143&rft.epage=149&rft_id=info:doi/10.1016%2Fj.jacc.2011.08.068&rft.externalDocID=S073510971104602X |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109711X00505%2Fcov150h.gif |